The serum soluble ASGR1 concentration is elevated in patients with coronary artery disease and is associated with inflammatory markers

Table 3 Association of sASGR1 with hs-CRP levels, WBC counts, and WBC subsets according to the different models

Models	Crude Model		Model I		Model II		Model III
	β	P	β	P	β	P	β	P
	(95% CI)	P	(95% CI)	P	(95% CI)	P	(95% CI)	P
hs-CRP	0.99	< 0.001	1.11	< 0.001	1	< 0.001	0.86	< 0.001
	(0.56, 1.42)		(0.79, 1.43)		(0.67, 1.33)		(0.51, 1.20)
WBC	0.17	0.002	0.17	< 0.001	0.12	0.004	0.13	0.004
	(0.06, 0.27)		(0.09, 0.26)		(0.04, 0.21)		(0.04, 0.22)
Neutrophil	0.14	0.002	0.14	< 0.001	0.09	0.011	0.1	0.008
	(0.05, 0.24)		(0.07, 0.22)		(0.02, 0.16)		(0.03, 0.18)
Monocyte	0.01	0.004	0.01	0.001	0.009	0.006	0.009	0.014
	(0.00, 0.02)		(0.00, 0.02)		(0.00, 0.02)		(0.00, 0.02)
Lymphocyte	0.008	0.575	0.01	0.302	0.01	0.392	0.01	0.577
	(-0.02, 0.04)		(-0.01, 0.04)		(-0.02, 0.04)		(-0.02, 0.04)

The multivariate regression stepwise models are shown. hs-CRP levels, WBC counts, and WBC subsets were the dependent variables. Model I was adjusted for age, sex and BMI; Model II was adjusted for Model I plus smoking status, hypertension, T2DM incidence, statin use, and CAD. Model III was adjusted for Model II plus TG, LDL-C and HDL-C

ISSN: 1476-511X